ื™ื•ื ืฉื ื™, 10 ืื•ื’ื•ืกื˜ 2026

Biotech

ืžื“ืข 7 ื—ื•ื“ืฉื™ื ืœืคื ื™

ืกื˜ืืจื˜-ืืค ื™ืฉืจืืœื™ ื‘ืชื—ื•ื ื”ื‘ื™ื ื” ื”ืžืœืื›ื•ืชื™ืช, Converge Bio, ื’ื™ื™ืก 25 ืžื™ืœื™ื•ืŸ ื“ื•ืœืจ ืœืฉื™ื ื•ื™ ืชื”ืœื™ืš ื’ื™ืœื•ื™ ื”ืชืจื•ืคื•ืช

ืกื˜ืืจื˜-ืืค ื™ืฉืจืืœื™ ื‘ืชื—ื•ื ื”ื‘ื™ื ื” ื”ืžืœืื›ื•ืชื™ืช, Converge Bio, ื’ื™ื™ืก 25 ืžื™ืœื™ื•ืŸ ื“ื•ืœืจ ื‘ืกื‘ื‘ ื’ื™ื•ืก ืžืกื•ื’ Series A, ืžื” ืฉืžื‘ื™ื ืืช ืกืš ื’ื™ื•ืกื™ื• ืœ-30 ืžื™ืœื™ื•ืŸ ื“ื•ืœืจ ืขื‘ื•ืจ ืคืœื˜ืคื•ืจืžืช ื’ื™ืœื•ื™ ื”ืชืจื•ืคื•ืช ืžื‘ื•ืกืกืช AI ืฉืœื”.